Literature DB >> 16815899

Dynamics of HIV neutralization by a microbicide formulation layer: biophysical fundamentals and transport theory.

Anthony R Geonnotti1, David F Katz.   

Abstract

Topical microbicides are an emerging HIV/AIDS prevention modality. Microbicide biofunctionality requires creation of a chemical-physical barrier against HIV transmission. Barrier effectiveness derives from properties of the active compound and its delivery system, but little is known about how these properties translate into microbicide functionality. We developed a mathematical model simulating biologically relevant transport and HIV-neutralization processes occurring when semen-borne virus interacts with a microbicide delivery vehicle coating epithelium. The model enables analysis of how vehicle-related variables, and anti-HIV compound characteristics, affect microbicide performance. Results suggest HIV neutralization is achievable with postcoital coating thicknesses approximately 100 mum. Increased microbicide concentration and potency hasten viral neutralization and diminish penetration of infectious virus through the coating layer. Durable vehicle structures that restrict viral diffusion could provide significant protection. Our findings demonstrate the need to pair potent active ingredients with well-engineered formulation vehicles, and highlight the importance of the dosage form in microbicide effectiveness. Microbicide formulations can function not only as drug delivery vehicles, but also as physical barriers to viral penetration. Total viral neutralization with 100-mum-thin coating layers supports future microbicide use against HIV transmission. This model can be used as a tool to analyze diverse factors that govern microbicide functionality.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16815899      PMCID: PMC1557566          DOI: 10.1529/biophysj.106.086322

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  38 in total

1.  Quantification of HIV in semen: correlation with antiviral treatment and immune status.

Authors:  P L Vernazza; B L Gilliam; J Dyer; S A Fiscus; J J Eron; A C Frank; M S Cohen
Journal:  AIDS       Date:  1997-07       Impact factor: 4.177

2.  Buccal permeation of buspirone: mechanistic studies on transport pathways.

Authors:  Raj Birudaraj; Bret Berner; Steve Shen; Xiaoling Li
Journal:  J Pharm Sci       Date:  2005-01       Impact factor: 3.534

3.  In vitro and in vivo characterization of a potential universal placebo designed for use in vaginal microbicide clinical trials.

Authors:  Deborah Tien; Roger L Schnaare; Feirong Kang; Gina Cohl; Timothy J McCormick; Thomas R Moench; Gustavo Doncel; Karen Watson; Robert W Buckheit; Mark G Lewis; Jill Schwartz; Karen Douville; Joseph W Romano
Journal:  AIDS Res Hum Retroviruses       Date:  2005-10       Impact factor: 2.205

4.  Erosion of microbicide formulation coating layers: effects of contact and shearing with vaginal fluid or semen.

Authors:  Anthony R Geonnotti; Jennifer J Peters; David F Katz
Journal:  J Pharm Sci       Date:  2005-08       Impact factor: 3.534

Review 5.  Perils at mucosal front lines for HIV and SIV and their hosts.

Authors:  Ashley T Haase
Journal:  Nat Rev Immunol       Date:  2005-10       Impact factor: 53.106

6.  Stoichiometry of antibody neutralization of human immunodeficiency virus type 1.

Authors:  Xinzhen Yang; Svetla Kurteva; Sandra Lee; Joseph Sodroski
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

7.  Stoichiometry of envelope glycoprotein trimers in the entry of human immunodeficiency virus type 1.

Authors:  Xinzhen Yang; Svetla Kurteva; Xinping Ren; Sandra Lee; Joseph Sodroski
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

8.  Analysis of the interaction between the HIV-inactivating protein cyanovirin-N and soluble forms of the envelope glycoproteins gp120 and gp41.

Authors:  B R O'Keefe; S R Shenoy; D Xie; W Zhang; J M Muschik; M J Currens; I Chaiken; M R Boyd
Journal:  Mol Pharmacol       Date:  2000-11       Impact factor: 4.436

9.  Subunit stoichiometry of human immunodeficiency virus type 1 envelope glycoprotein trimers during virus entry into host cells.

Authors:  Xinzhen Yang; Svetla Kurteva; Xinping Ren; Sandra Lee; Joseph Sodroski
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

10.  Baseline dimensions of the human vagina.

Authors:  Kurt T Barnhart; Adriana Izquierdo; E Scott Pretorius; David M Shera; Mayadah Shabbout; Alka Shaunik
Journal:  Hum Reprod       Date:  2006-02-14       Impact factor: 6.918

View more
  18 in total

1.  Enzymatic triggered release of an HIV-1 entry inhibitor from prostate specific antigen degradable microparticles.

Authors:  Meredith R Clark; Hyder A Aliyar; Chang-won Lee; Julie I Jay; Kavita M Gupta; Karen M Watson; Russell J Stewart; Robert W Buckheit; Patrick F Kiser
Journal:  Int J Pharm       Date:  2011-04-12       Impact factor: 5.875

2.  A model of transluminal flow of an anti-HIV microbicide vehicle: Combined elastic squeezing and gravitational sliding.

Authors:  Andrew J Szeri; Su Chan Park; Stéphane Verguet; Aaron Weiss; David F Katz
Journal:  Phys Fluids (1994)       Date:  2008-08-21       Impact factor: 3.521

3.  Transport theory for HIV diffusion through in vivo distributions of topical microbicide gels.

Authors:  Bonnie E Lai; Marcus H Henderson; Jennifer J Peters; David K Walmer; David F Katz
Journal:  Biophys J       Date:  2009-11-04       Impact factor: 4.033

4.  Predicting first traversal times for virions and nanoparticles in mucus with slowed diffusion.

Authors:  Austen M Erickson; Bruce I Henry; John M Murray; Per Johan Klasse; Christopher N Angstmann
Journal:  Biophys J       Date:  2015-07-07       Impact factor: 4.033

5.  Transient antibody-mucin interactions produce a dynamic molecular shield against viral invasion.

Authors:  Alex Chen; Scott A McKinley; Simi Wang; Feng Shi; Peter J Mucha; M Gregory Forest; Samuel K Lai
Journal:  Biophys J       Date:  2014-05-06       Impact factor: 4.033

6.  Optical imaging and analysis of human vaginal coating by drug delivery gels.

Authors:  Marcus H Henderson; Grace M Couchman; David K Walmer; Jennifer J Peters; Derek H Owen; Matthew A Brown; Michael L Lavine; David F Katz
Journal:  Contraception       Date:  2006-10-31       Impact factor: 3.375

7.  Movements of HIV-virions in human cervical mucus.

Authors:  Hacène Boukari; Beda Brichacek; Pamela Stratton; Sheila F Mahoney; Jeffrey D Lifson; Leonid Margolis; Ralph Nossal
Journal:  Biomacromolecules       Date:  2009-09-14       Impact factor: 6.988

8.  The Effect of Surface Tension on the Gravity-driven Thin Film Flow of Newtonian and Power-law Fluids.

Authors:  Bin Hu; Sarah L Kieweg
Journal:  Comput Fluids       Date:  2012-07-15       Impact factor: 3.013

9.  Using Computational Modeling To Optimize the Design of Antibodies That Trap Viruses in Mucus.

Authors:  Timothy Wessler; Alex Chen; Scott A McKinley; Richard Cone; Gregory Forest; Samuel K Lai
Journal:  ACS Infect Dis       Date:  2015-10-17       Impact factor: 5.084

10.  Modulation of Viscoelasticity and HIV Transport as a Function of pH in a Reversibly Crosslinked Hydrogel.

Authors:  Julie I Jay; Shetha Shukair; Kristofer Langheinrich; Melissa C Hanson; Gianguido C Cianci; Todd J Johnson; Meredith R Clark; Thomas J Hope; Patrick F Kiser
Journal:  Adv Funct Mater       Date:  2009-09-23       Impact factor: 18.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.